Key statistics
As of last trade, NovaBay Pharmaceuticals Inc (NBY:ASQ) traded at 0.70, 93.85% above the 52 week low of 0.3611 set on Aug 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.715 |
---|---|
High | 0.715 |
Low | 0.6806 |
Bid | 0.692 |
Offer | 0.71 |
Previous close | 0.7198 |
Average volume | 109.98k |
---|---|
Shares outstanding | 4.89m |
Free float | 4.89m |
P/E (TTM) | -- |
Market cap | 3.52m USD |
EPS (TTM) | -53.22 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 17:58 GMT.
More ▼
- Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
- NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
- NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
- NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
- NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
More ▼